![Michael Cloonan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Cloonan
Algemeen Directeur bij
SIONNA THERAPEUTICS, INC.
Vermogen: 26 M $ op 31-07-2026
Profiel
Michael Cloonan is Chief Operating Officer van SAGE Therapeutics, Inc. In het verleden bekleedde hij de positie van Senior Vice President-US Commercial bij Biogen, Inc. De heer Cloonan behaalde een MBA aan de Darden School of Business van de Universiteit van Virginia en een bachelorgraad aan het College of the Holy Cross (Massachusetts).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-04-2026 | 547.343 ( 1,21% ) | 26 M $ | 31-07-2026 |
Actieve functies van Michael Cloonan
| Bedrijven | Functie | Begin |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | Algemeen Directeur | 01-05-2021 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Consultant / Adviseur | - |
Eerdere bekende functies van Michael Cloonan
| Bedrijven | Functie | Einde |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 02-06-2025 |
| SAGE THERAPEUTICS, INC. | Operationeel Directeur | 03-05-2021 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Michael Cloonan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
90
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
